Results 231 to 240 of about 7,421,514 (390)
Next‐generation proteomics improves lung cancer risk prediction
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source
Rational deployment of molecular markers for the benzenediol lactones and related compounds biosynthesis in filamentous fungi. [PDF]
Kawaliło M +6 more
europepmc +1 more source
Assessing Fungal Biodiversity Using Molecular Markers
Md. Shamim +5 more
openalex +1 more source
Exploiting metabolic adaptations to overcome dabrafenib treatment resistance in melanoma cells
We show that dabrafenib‐resistant melanoma cells undergo mitochondrial remodeling, leading to elevated respiration and ROS production balanced by stronger antioxidant defenses. This altered redox state promotes survival despite mitochondrial damage but renders resistant cells highly vulnerable to ROS‐inducing compounds such as PEITC, highlighting redox
Silvia Eller +17 more
wiley +1 more source
Molecular markers associated with elevated colorectal cancer risk: a mini review. [PDF]
Szuman M +9 more
europepmc +1 more source
Diversity analysis of some selected rice genotypes through SSR- based molecular markers
M. H. Shahriar +3 more
openalex +2 more sources
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad +35 more
wiley +1 more source
GLUT and FAPα as molecular markers for interstitial lung disease in systemic sclerosis. [PDF]
Broens B +10 more
europepmc +1 more source

